// App-Quantinova.ai

P1131 : POST HOC ANALYSIS OF PATIENTS WITH HIGHLY PROLIFERATIVE VARIANTS OF MANTLE CELL LYMPHOMA TREATED WITH ACALABRUTINIB

Researchers

Presenter

  • Steven Le Gouill

Principal Investigators

  • Monika Dlugosz-Danecka

  • Simon Rule

  • Pier Luigi Zinzani

  • Andre Goy

  • Stephen D. Smith

  • Jeanette K. Doorduijn

  • Carlos Panizo

  • Bijal Shah

  • Andrew Davies

  • Richard Eek

  • Eric Jacobsen

  • Arnon P. Kater

  • Tadeusz Robak

  • Preetesh Jain

  • Roser Calvo

  • Helen Yang

  • Michael Wang

Medical Centers

  • MD Anderson Cancer Center, Univers

  • Institut Curie,Paris,Frankreich

  • Clinica Universidad de Navarra, Pamplona, Spain

  • AstraZeneca, South San Francisco,California,Estados Unidos

  • Erasmus MC,

  • John Theurer Can

  • Clinica Universidad de Navarra, Pamplona, Spain

  • AstraZeneca, Gaithersberg, MD, United States,

  • MD Anderson Cancer Center, University of Texas, Houston, TX

  • University of Washington, Fred Hutch

  • Moffitt Cancer Center,Tampa,Verenigde Staten

  • Border Medical Oncology,Albury, NSW,Australie

  • The Maria Sklodowska-Curie National Research Institute of Oncology in Warsaw,Warsaw,Poland

  • The Maria Sklodowska-Curie National Research Institute of Oncology in Warsaw,Warsaw,Poland

  • Moffitt Cancer Center, Tampa, FL

  • Mofitt Cancer Center,Tampa, FL,Estados Unidos

  • Dana-Farb

  • Institut Curie,Paris,Frankreich

  • AstraZeneca,South San Francisco, CA,United St

  • Border Medical Oncology,Albury,

  • John Theurer Cancer Centre, Hackensack University Medical Center, Hackensack, NJ

  • Amsterdam University Medical Center, Amsterdam, on behalf of HOVON,Amsterdam,Paesi Bassi

  • Amsterdam University Medical Center, Amsterdam, on behalf of Hovon, Amsterdam, Netherlands

  • MD Anderson Cancer Center, University of Texas, Houston, TX

  • Clinica Universidad de Navarra,Madrid,Испания

  • Plymouth University Medical School, Plymouth,Verenigd Koninkrijk

  • Copernicus Memorial Hospital, Medical University of Lodz, Lodz, Poland

  • U932,Institut Curie,Paris,France

  • MD Anderson Cancer Center, University of Texas, Houston, TX

  • Clinica Universidad de Navarra, Pamplona, Spain

  • MD Anderson Cancer Center,University of Texas,Houston,Vereinigte Staaten

  • Dana–Farber Cancer Institute, Harvard Medical School, Boston, MA, United States

  • AstraZeneca,Gaithersburg,États-unis

  • Moffitt Cancer Center, Tampa, Florida, United States

  • IRCCS Azienda Ospedaliero‐Universitaria di Bologna, Istituto di Ematologia 'Seràgnoli', Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Università di Bologna,Bologna,Italia

  • Institut Curie,Paris,Франция

  • AstraZeneca,Gaithersburg, MD,Verenigde Staten

  • AstraZeneca,Gaithersburg, MD,Verenigde Staten

  • AstraZeneca,Gaithersburg,Estados Unidos

  • AstraZeneca, Gaithersburg, MD

  • Copernicus Memorial Hospital, Medical University of Lodz, Lodz, Poland

  • Institut Curie, Paris Cedex, France

  • Amsterdam University Medical Center, Amsterdam, on behalf of Hovon, Amsterdam, Netherlands

  • Plymouth University Medical School, Plymouth,Verenigd Koninkrijk

  • University of Washington/Fred Hutchinson Cancer Research Center,Seattle,États-unis

  • Dana–Farber Cancer Institute, Harvard Medical School, Boston, MA, United States

  • John Theurer Cancer Centre, Hackensack University Medical Center, Hackensack, NJ

  • Dana–Farber Cancer Institute, Harvard Medical School, Boston, MA, United States

  • Erasmus MC Cancer Institute, HOVON Lunenburg Lymphoma Phase I/II Consortium,Rotterdam,Niederlande

  • Clinica Universidad de Navarra, Pamplona, Spain

  • Copernicus Memorial Hospital, Medical University of Lodz, Lodz, Poland

  • IRCCS Azienda Osp

  • Moffitt Cancer Center,Tampa, FL,Stati Uniti

  • Moffitt Cancer Center,Tampa, FL,Stati Uniti

  • Cancer Research UK/NIHR Experimental Cancer Medicines Centre, University of Southampton,Southampton,United Kingdom

  • John Theurer Cancer Centre, Hackensack University Medical Center, Hackensack, NJ

  • Cancer Research UK/NIHR Experimental Cancer Medicines Centre, University of Southampton,Southampton,United Kingdom

  • Border Medical Oncology,Albury, NSW,Australie

  • Border Medical Oncology,Albury, NSW,Australie

  • IRCCS Azienda Ospedaliero‐Universitaria di Bologna, Istituto di Ematologia 'Seràgnoli', Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Università di Bologna,Bologna,Italia

  • AstraZeneca, South San Francisco,California,Estados Unidos

  • Border Medical Oncology,Albury, NSW,Australie

  • AstraZeneca, South San Francisco,California,Estados Unidos

  • Cancer Research UK/NIHR Experimental Cancer Medicines Centre, University of Southampton,Southampton,United Kingdom

  • University of Washington/Fred Hutchinson Cancer Research Center,Seattle,États-unis

  • Plymouth University Medical School,

  • University of Washington/Fred Hutchinson Cancer Research Center,Seattle,États-unis

  • Clinica Universidad de Navarra, Pamplona, Spain

  • Plymouth University Medical School, Plymouth, United Kingdom

  • Erasmus MC Cancer Institute, HOVON Lunenburg Lymphoma Phase I/II Consortium,Rotterdam,Niederlande

  • Dana–Farber Cancer Institute, Harvard Medical School, Boston, MA, United States

  • AstraZeneca,South San Francisco, CA,United States

  • Erasmus MC Cancer Institute, HOVON Lunenburg Lymphoma Phase I/II Consortium,Rotterdam,Niederlande

  • Erasmus MC Cancer Institute, HOVON Lunenburg Lymphoma Phase I/II Consortium,Rotterdam,Niederlande

  • AstraZeneca,South San Francisco,Vereinigte Staaten

  • Border Medical Oncology,Albury, NSW,Australie

  • Maria Sklodow

  • Copernicus Memorial Hospital, Medical University of L

  • Amsterdam University Medical Centers, Amsterdam

  • Clinica Universidad de Navarra, Pamplona, Spain

  • Clínica Universidad d

  • Moffitt Cancer Center,Tampa,Verenigde Staten

  • Institut Curie,Paris,Frankreich

  • University of Washington, Fred Hutchinson Cancer Research Center,Seattle, WA,United States

  • AstraZeneca,Gaithersburg,Stati Uniti

  • The Maria Sklodowska-Curie National Research Institute of Oncology in Warsaw,Warsaw,Poland

  • The Maria Sklodowska-Curie National Research Institute of Oncology in Warsaw,Warsaw,Poland

  • MD Anderson Cancer Center, University of Texas, Houston, TX

  • Amsterdam University Medical Center, Amsterdam, on behalf of HOVON,Amsterdam,Paesi Bassi

  • Clinica Universidad de Navarra, Pamplona, Spain

  • Institut Curie,Paris,Frankreich

  • AstraZeneca,South San Francisco,Vereinigte Staaten

  • Border Medical Oncology,Albury, NSW,Австралия

  • Cancer R

  • Copernicus Memorial Hospital, Medical University of Lodz, Lodz, Poland

  • Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA

  • Plymouth University Medical School, Plymouth, United Kingdom

  • Plymouth University Medical School, Plymouth, United Kingdom

  • John Theurer Cancer Centre, Hackensack University Medical Center, Hackensack, NJ

  • Plymouth University Medical School,Plymouth,Royaume-uni

Locations

  • France

  • United States

  • Poland

  • United Kingdom

  • Italy

  • Spain

  • Australia

  • Turkey

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Mantle cell lymphoma

Biomarkers

  • N/A

Drug/Treatment

  • ACP-196

Outcome

  • N/A

Study Design

  • N/A

Phase

  • II

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved